Skip to main content
. 2022 Sep 16;14(9):2052. doi: 10.3390/v14092052

Figure 4.

Figure 4

Impact of oligonucleotide uptake in the liver versus immunostimulatory impact. A map of the most prevalent liver cell types is at upper left. Relative immunoreactivity to oligonucleotides via TLR3/7/8 and 9 is indicated at upper right. Cell uptake with oligonucleotides are indicated as unconjugated ASOs (middle left), LNP formulation siRNA (lower left) and GalNAc conjugated-ASO or siRNA (lower right). Stronger cellular accumulation is indicated by darker shading.